Rami Komrokji, MD, Moffitt Cancer Center

home / authors / rami-komrokji-md-moffitt-cancer-center

Articles

The Future of MDS Management

The Future of MDS Management

Amy DeZern, MD, MHS, Sidney Kimmel Comprehensive Cancer Center;Rami Komrokji, MD, Moffitt Cancer Center
November 18th 2020

Read More

Overview of Luspatercept-aamt as MDS Treatment

Overview of Luspatercept-aamt as MDS Treatment

Amy DeZern, MD, MHS, Sidney Kimmel Comprehensive Cancer Center;Rami Komrokji, MD, Moffitt Cancer Center
November 18th 2020

Read More

The Role of Hypomethylating Agents and Transplantation

The Role of Hypomethylating Agents and Transplantation

Amy DeZern, MD, MHS, Sidney Kimmel Comprehensive Cancer Center;Rami Komrokji, MD, Moffitt Cancer Center
November 18th 2020

Read More

Initiating First-Line Treatment

Initiating First-Line Treatment

Amy DeZern, MD, MHS, Sidney Kimmel Comprehensive Cancer Center;Rami Komrokji, MD, Moffitt Cancer Center
November 18th 2020

Read More

The Role of Supportive Care 

The Role of Supportive Care 

Amy DeZern, MD, MHS, Sidney Kimmel Comprehensive Cancer Center;Rami Komrokji, MD, Moffitt Cancer Center
November 18th 2020

Read More

IPSS/IPSS-R Reliability in Various Disease Settings 

IPSS/IPSS-R Reliability in Various Disease Settings 

Amy DeZern, MD, MHS, Sidney Kimmel Comprehensive Cancer Center;Rami Komrokji, MD, Moffitt Cancer Center
November 18th 2020

Read More

Disease-Course Differentiation: Low Risk and High Risk

Disease-Course Differentiation: Low Risk and High Risk

Amy DeZern, MD, MHS, Sidney Kimmel Comprehensive Cancer Center;Rami Komrokji, MD, Moffitt Cancer Center
November 18th 2020

Read More

Challenges of MDS Management

Challenges of MDS Management

Amy DeZern, MD, MHS, Sidney Kimmel Comprehensive Cancer Center;Rami Komrokji, MD, Moffitt Cancer Center
November 18th 2020

Read More

Ensuring an Accurate Diagnosis

Ensuring an Accurate Diagnosis

Amy DeZern, MD, MHS, Sidney Kimmel Comprehensive Cancer Center;Rami Komrokji, MD, Moffitt Cancer Center
November 18th 2020

Read More

Heterogeneity and Presentation of MDS

Heterogeneity and Presentation of MDS

Amy DeZern, MD, MHS, Sidney Kimmel Comprehensive Cancer Center;Rami Komrokji, MD, Moffitt Cancer Center
November 18th 2020

Read More

Latest Updated Articles

Sarwish Rafiq, PhD
Published: July 9th 2024 | Updated: July 10th 2024
Dr Rafiq on Novel Strategies for CAR T-Cell Engineering in Solid Tumors
Jens Hoeppner, FAChirg, FACS, MD
Published: June 2nd 2024 | Updated: June 3rd 2024
Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Published: July 25th 2024 | Updated: July 27th 2024
Dr Rotow on the Impact of Biomarker Testing on NSCLC Treatment Outcomes
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Published: July 25th 2024 | Updated: July 27th 2024
Dr Sabari on Barriers to Biomarker Testing in NSCLC
5 KOLs are featured in this series.
Published: July 18th 2024 | Updated: July 27th 2024
Treatment Considerations and Patient Selection for CAR T-cell Therapy in R/R ALL
5 KOLs are featured in this series.
Published: July 18th 2024 | Updated: July 27th 2024
Expert Insights on ZUMA-3 Data Updates: 4-Year Follow-up and Real World Data